Arkolith/Insider Trading/EIGR/Form 4

Glenn Jeffrey S

DirectorEiger BioPharmaceuticals, Inc. (EIGR) · full profile →Form 4 · filed Dec 27, 2022
Net Buying
Open-Market Buys
$128K
Open-Market Sells
$0
Net Open-Market Flow
$128K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 22, 2022Buy(P)100K$1.28$128K182K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-22-047070) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML